PATRICE AUGUSTYNIAK: Open Payments
NPI 1124786702 · SUN CITY WEST, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,399 in 60 payments from 13 companies in 2025. Trend: 2023 $1,366 · 2024 $1,661 · 2025 $1,399
Food & beverage: $1,399
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 6 | $314 |
| AstraZeneca Pharmaceuticals LP | 12 | $261 |
| ABBVIE INC. | 10 | $244 |
| Novo Nordisk Inc | 8 | $158 |
| PFIZER INC. | 10 | $153 |
| Corcept Therapeutics | 4 | $92 |
| Lilly USA, LLC | 3 | $46 |
| Merck Sharp & Dohme LLC | 2 | $41 |
| Boston Scientific Corporation | 1 | $21 |
| Exact Sciences Corporation | 1 | $19 |
Products named: UBRELVY, OTEZLA, AIRSUPRA, REPATHA, FARXIGA, Korlym, Wegovy, Ozempic.
Industry payments across AZ — which companies pay providers there.
